【Cancer treatment from the same day without hospitalization】
1. Pre-symptomatic patients with a family history of cancer who want to suppress the cancer onset
2. Those who wish to prevent recurrence after cancer treatment (surgery, anticancer drug treatment, etc.)
3. Stage III/IV or above
4. Those who have no treatment left and were recommended hospice
A clinic specializing in cancer treatment (blood cancer such as leukemia is not applicable)

Cancer treatment that supports "how to live"
At Takara Clinic, we propose treatment methods that match the patient's medical condition. It can also be used by those who are undergoing anticancer drug treatment at other medical institutions.
We support cancer patients who wish to continue working and living a normal life while coexisting with cancer so that they can live as long as possible with a high quality of life and live in their own way.

Location

〒1410022
9F Taisei building, 2-3-2 Higashigotanda, Shinagawa-ku, Tokyo Tokyo

Website

https://www.takara-clinic.com/wordpress/wp-content/uploads/2015/10/MX-2640FN_20151024_1454422.pdf

Specialty

Oncology, Internal Medicine, Surgery,Respiratory Medicine, Allergy

Facility details

【ACSESS】
30 minutes from Haneda airport by public transportation. It is located in Gotanda Station, JR yamanote line, 3minutes walk from east exit near Mitsui Garden hotel

【MEDICAL INSTRUMENT】
Low-dose radiation hormesis device Microwave therapy. BMW therapy (Bilateral Micro-Wave) device

【EQUIPEMENT】
Adapting a natural substance activation method, the entire clinic is negatively ionized to create an oasis in the busy city. In addition, we are working on preventing hospital-acquired infections by ionizing and inactivating viruses.

【OTHERS】
It can be used in combination with multidisciplinary therapy. It is especially compatible with radiation. IMF therapy can be injected at home by yourself.

Available Programs

• IMF therapy (Immunomodulatory Factor Therapy)【TAKARA　CLINIC】

  This is a method to activate immune cells by stimulating the internal environment of cancer patients whose immune system is weakened. By increasing NK cell activity at the cytokine level, we create an inner environment that is difficult for “cancer cells” to live in, and we are achieving therapeutic results.

  In order to bring out the inherent power of NK cell it self maximally, immune cells are stimulated by the action of proteins secreted from external immune cells. It is a method that induces inherent NK cell activity of the immune system. In addition, it has been reported that it has the action to strengthens the function of helper T cells that help to educate killer T cells, or it assists the proliferation of killer T cells, and strengthens the action of NK cells. 3 treatments per week for 1 month or 3 months protocols is performed. We have a track record of administering about 500 injections per year at our hospital. An increase in INF-γ (interferon gamma) which shows immune activity (a cytokine secreted mainly by NK cells and T cells, which has the effect to enhance inflammation by leukocytes) has been observed after administration.

  View Details

• TCTP Therapy (Total Cancer Treatment Protocol)【TAKARA　CLINIC】

  TCTP Therapy (Total Cancer Treatment Protocol) is Takara Clinic's proprietary integrated cancer immunotherapy protocol that combines local tumor control through radiation therapy with systemic immune regulation using autologous cultured dendritic cells, macrophages, and T lymphocytes.
  
  This comprehensive treatment approach is designed to address both the local cancer lesion and the body's overall immune environment as part of an individualized cancer treatment strategy.

  TCTP Therapy (Total Cancer Treatment Protocol) is a comprehensive cancer treatment strategy that combines local tumor control with systemic immune regulation. In this protocol, immune cells collected from the patient's own blood—including dendritic cells, macrophages, and T lymphocytes—are cultured and activated before being administered directly into or near the tumor. In addition, the combination of radiation therapy is intended to improve the immune microenvironment surrounding the tumor, with the goal of achieving both local anti-tumor effects and systemic immune activation. This therapy is provided under an appropriate management system following the acceptance of a regenerative medicine provision plan and assignment of a plan number in accordance with Japan's Act on the Safety of Regenerative Medicine administered by the Ministry of Health, Labour and Welfare (MHLW). Please note: Because this therapy uses the patient's own cells, a certain period of time is required for cell processing and culture. Therefore, treatment cannot be performed on the same day as blood collection.

  View Details